Synairgen has specialised scientific research and clinical teams dedicated to drug discovery and development in asthma, COPD and other respiratory diseases. Their main activities are summarised opposite:

Research

• Advanced human in vitro models generated from the BioBank samples, including use of virus infection models (experienced in use of rhinovirus, RSV, influenza etc.)
• Lung biomarker validation and assessment
• Application of human tissue models for:
  • Target discovery
  • Target validity
  • Support clinical activity

Clinical

• Extensive BioBank of relevant tissue, cells, blood and airway secretions from volunteers (both diseased and healthy)
• Phase I &II trial capability in respiratory patients during naturally acquired cold infections

For more detailed information please go to Technology and Programmes